Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 1/20 | 0.53 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.53 |
| ▸ | PIM1 | P11309 | 1/20 | 0.53 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.53 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.53 |
| ▸ | FABP4 | P15090 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.51 |
| ▸ | RECQL | P46063 | 2/20 | 0.51 |
| ▸ | APAF1 | O14727 | 1/20 | 0.51 |
| ▸ | CASP6 | P55212 | 1/20 | 0.51 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.51 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.51 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | FABP3 | P05413 | 2/20 | 0.50 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28142654 | 0.83 | HPGD (0.54) | MAPK8KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL5925582 | 0.81 | KDM4E (0.50) | CDC25BCHEK1PIM1MAPK8CLK4 | |
| SCHEMBL7523030 | 0.79 | HCAR2 (0.49) | CDC25BCHEK1PIM1MAPK8CLK4 | |
| SCHEMBL7517565 | 0.79 | KDM4E (0.58) | MAPK8FABP4KMT2AKDM4EALDH1A1 | |
| SCHEMBL7519507 | 0.79 | FABP4 (0.47) | CDC25BCHEK1PIM1MAPK8CLK4 | |
| SCHEMBL3629659 | 0.78 | KMT2A (0.57) | CHEK1PIM1MAPK8CLK4KMT2A | |
| SCHEMBL11433582 | 0.78 | KMT2A (0.44) | KMT2AKDM4EALDH1A1MEN1ALOX15 | |
| SCHEMBL7034926 | 0.77 | MAPT (0.74) | CDC25BFABP4KMT2AKDM4ERECQL | |
| N-Methylanthranilic Acid SCHEMBL130356 | 0.77 | KDM4E (0.64) | FABP4KMT2AKDM4EALDH1A1MEN1 | |
| N-Methylanthranilic Acid SCHEMBL29381752 | 0.77 | KDM4E (0.64) | FABP4KMT2AKDM4EALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024090362-A1 | CHARGE-TRANSPORTING COMPOSITION | 日産化学株式会社 | 2024-05-02 | — | — | WO | disclosed |
| EP-2634204-B1 | CONDUCTIVE ANILINE POLYMER, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CONDUCTIVE FILM | MITSUBISHI CHEM CORP (JP) | 2021-03-31 | — | — | EP | disclosed |
| US-9799420-B2 | Conductive aniline polymer, method for producing same, and method for producing conductive film | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-10-24 | — | — | US | disclosed |
| US-9679673-B2 | Conductive composition, conductor and solid electrolytic capacitor using conductive composition | MITSUBISHI RAYON CO., LTD. (JP) | 2017-06-13 | — | — | US | disclosed |
| US-20160078978-A1 | CONDUCTIVE COMPOSITION, CONDUCTOR AND SOLID ELECTROLYTIC CAPACITOR USING CONDUCTIVE COMPOSITION | MITSUBISHI RAYON CO., LTD. (JP) | 2016-03-17 | — | — | US | disclosed |
| US-20150179295-A1 | CONDUCTIVE ANILINE POLYMER, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CONDUCTIVE FILM | MITSUBISHI RAYON CO., LTD. (JP) | 2015-06-25 | — | — | US | disclosed |
| EP-2700676-A1 | CONDUCTIVE COMPOSITION, CONDUCTOR USING CONDUCTIVE COMPOSITION, AND SOLID ELECTROLYTIC CAPACITOR | Mitsubishi Rayon Co., Ltd. (JP) | 2014-02-26 | — | — | EP | disclosed |
| US-20140043731-A1 | CONDUCTIVE COMPOSITION, CONDUCTOR AND SOLID ELECTROLYTIC CAPACITOR USING CONDUCTIVE COMPOSITION | MITSUBISHI RAYON CO., LTD. (JP) | 2014-02-13 | — | — | US | disclosed |
| EP-2634204-A1 | CONDUCTIVE ANILINE POLYMER, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CONDUCTIVE FILM | Mitsubishi Rayon Co., Ltd. (JP) | 2013-09-04 | — | — | EP | disclosed |
| US-20130209667-A1 | CONDUCTIVE ANILINE POLYMER, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CONDUCTIVE FILM | MITSUBISHI RAYON CO., LTD. (JP) | 2013-08-15 | — | — | US | disclosed |
| US-20080119470-A1 | Neurologically-Active Compounds | XOMA TECHNOLOGY LTD. | 2008-05-22 | — | — | US | disclosed |
| EP-1737831-A1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | Prana Biotechnology Limited (AU) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005095360-A1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | PRANA BIOTECHNOLOGY LIMITED (AU) | 2005-10-13 | — | — | WO | disclosed |
| EP-0834885-B1 | Method for producing soluble conductive polymers having acidic groups | MITSUBISHI RAYON CO (JP) | 2002-01-02 | — | — | EP | disclosed |
| US-5980784-A | SUBJECTING TO ELECTROLYTIC POLYMERIZATION AT LEAST ONE COMPOUND SELECTED FROM THE GROUP CONSISTING OF ACIDIC GROUP SUBSTITUTED ANILINES, PYRROLES, THIOPHENES, FURANS, SELENOPHENES, TELLUROPHENES, ISOTHIANAPHTHENES, IN BASE | MITSUBISHI RAYON CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0834885-A2 | Method for producing soluble conductive polymer having acidic groups | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1998-04-08 | — | — | EP | disclosed |
| EP-0190915-B1 | Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2]octan-3-yl) aminobenzamides | SYNTHELABO (FR) | 1992-10-28 | — | — | EP | disclosed |
| US-4870181-A | AMIDATION OF 3-AMINOQUINUCLIDINE SALT | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-09-26 | — | — | US | disclosed |
| CN-1033380-A | Compound | SMITHKLINE BECKMAN INTERCREDIT (NL) | 1989-06-14 | — | — | CN | disclosed |
| EP-0190915-A2 | Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2]octan-3-yl) aminobenzamides | SYNTHELABO (FR) | 1986-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119470-A1 | Neurologically-Active Compounds | ACHE, PSEN1, PSEN2 | CDC25B 4382/4885CHEK1 2066/4885PIM1 3819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.